The Cell Sciences Imaging Facility (CSIF) Shared Resource provides access to and training in high resolution, state-of-the-art imaging technologies. These technologies are essential tools for studying the molecular, sub-cellular and cellular mechanisms of cancer The CSIF is organized into three interdependent resources: the Fluorescence Microscopy Core (FMC), the Electron Microscopy Core (EMC) and the Array Tomography Core (ATC). The facility's FMC houses three advanced imaging systems that provide confocal, deconvolution, and 2-photon fluorescent light microscopy technologies for imaging both fixed and live cells and tissues. The Facility's EMC offers complete sample preparation and training in both transmission and scanning electron microscopy technologies for ultra structural and immunohistochemical studies. The Facility's ATC provides complete array tomography services, from array generation and labeling to automated imaging of immunolocalized arrays. Additional equipment includes all ancillary equipment necessary for sample preparation and advanced software resources for 3D, 4D interactive volume imaging of data sets, as well as advanced deconvolution software packages. The CSIF's current operating budget is approximately $500,000. The CSIF recovers, on average, 84% of this cost through user fees with the remaining 16% covered by the Cancer Center and institutional funds. Additionally, institutional funds support the growth of the CSIF by funding capital equipment needs not easily funded through grants. Leadership is provided by the CSIF's Advisory Committee. This nine member committee includes Dr. Stephen Smith, a world expert in microscopy, Mr. Mulholland, Director of the CSIF, and seven researchers from the Cancer Center, School of Medicine and School of the Humanities and Sciences. Forty-six Cancer Center members currently use the CSIF resources. Future goals of the CSIF include providing improved live cell and tissue imaging technologies. The CSIF also continues to actively develop its cryo and immuno-EM technologies and is developing correlative methods for light and electron microscopy, all of which will be essential to the study and understanding of the molecular and structural basis of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-07
Application #
8475460
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
7
Fiscal Year
2013
Total Cost
$56,585
Indirect Cost
$4
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Ganjoo, Kristen; Hong, Fangxin; Horning, Sandra J et al. (2014) Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leuk Lymphoma 55:768-72
Chiou, Shin-Heng; Kim-Kiselak, Caroline; Risca, Viviana I et al. (2014) A conditional system to specifically link disruption of protein-coding function with reporter expression in mice. Cell Rep 7:2078-86
Zhu, Gefei Alex; Danial, Christina; Liu, Andy et al. (2014) Overall and progression-free survival in metastatic basosquamous cancer: a case series. J Am Acad Dermatol 70:1145-6
Caswell, Deborah R; Chuang, Chen-Hua; Yang, Dian et al. (2014) Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discov 4:781-9
Bartroff, Jay; Lai, Tze Leung; Narasimhan, Balasubramanian (2014) A new approach to designing phase I-II cancer trials for cytotoxic chemotherapies. Stat Med 33:2718-35
Kohrt, Holbrook E; Thielens, Ariane; Marabelle, Aurelien et al. (2014) Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood 123:678-86
DiCarlo, Joseph; Agarwal-Hashmi, Rajni; Shah, Ami et al. (2014) Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 20:361-9
Chang, Serena; Kohrt, Holbrook; Maecker, Holden T (2014) Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother 63:713-9
Ansari, Celina; Tikhomirov, Grigory A; Hong, Su Hyun et al. (2014) Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. Small 10:566-75, 417
Lavori, Philip W; Dawson, Ree (2014) Introduction to dynamic treatment strategies and sequential multiple assignment randomization. Clin Trials 11:393-399

Showing the most recent 10 out of 24 publications